Management of dyslipidemia in diabetes

Cardiology in Review
Maria P Solano, Ronald B Goldberg

Abstract

Diabetes is associated with a high risk of cardiovascular disease. The management of dyslipidemia, a well-recognized and modifiable risk factor among patients with type 2 diabetes, is an important element in the multifactorial approach to prevent coronary heart disease. Diabetic dyslipidemia typically consists of elevated triglyceride, low high-density lipoprotein cholesterol (HDL-C), and the predominance of small dense low-density lipoprotein (LDL) particles. LDL cholesterol (LDL-C) levels in patients with diabetes are similar to those found in the rest of the population. During the past few years, clinical trials have provided evidence that lipid-lowering therapy has a similar beneficial effect on cardiovascular outcomes in diabetic and nondiabetic individuals. According to current guidelines, the primary lipid target is an LDL-C <100 mg/dL (<70 mg/dL in very high-risk patients) and, to this end, statins are the agents of choice. The appropriate management of dyslipidemia in patients with diabetes, particularly in individuals with low LDL-C, remains controversial. To achieve lipid targets, attention should be directed first toward nonpharmacologic therapeutic interventions to control dyslipidemia, such as diet, exercise, smok...Continue Reading

References

Jan 1, 1979·Circulation·W B Kannel, D L McGee
Jan 27, 1975·JAMA : the Journal of the American Medical Association
Dec 1, 1992·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·K R FeingoldR M Krauss
Jul 4, 1990·JAMA : the Journal of the American Medical Association·L R PierceT P Gross
Oct 1, 1988·Annals of Internal Medicine·R A Levine
Oct 1, 1988·Annals of Internal Medicine·P Reaven, J L Witztum
Apr 1, 1987·Diabetes/metabolism Reviews·K PyöräläM Uusitupa
Aug 1, 1987·The American Journal of Medicine·J R Crouse
Feb 1, 1985·Paraplegia·P Harris
Oct 1, 1984·The American Journal of Cardiology·J W SmithR Serokman
Mar 2, 1994·JAMA : the Journal of the American Medical Association·J M McKenneyV M Chinchili
May 1, 1993·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·A D Sniderman, K Cianflone
Jun 1, 1996·Arteriosclerosis, Thrombosis, and Vascular Biology·C E LloydT J Orchard
May 1, 1997·Southern Medical Journal·A TalW Isley
Feb 19, 1998·The American Journal of Cardiology·P B DuellD R Illingworth
Mar 13, 1998·The American Journal of Clinical Nutrition·A Garg
Apr 4, 1998·The American Journal of Cardiology·R L Ellen, R McPherson
May 8, 1998·Diabetes Care·C E FriedbergD E Grobbee
Jan 23, 1999·The American Journal of Cardiology·R A Kreisberg
Feb 4, 1999·Clinical Cardiology·E A Iliadis, R S Rosenson
Apr 6, 1999·The American Journal of Cardiology·G W PogsonB G Carper
Sep 29, 1999·The American Journal of Clinical Nutrition·J W AndersonB P Daggy

❮ Previous
Next ❯

Citations

Mar 17, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dimitrios P Kontoyiannis
Dec 22, 2010·Lipids in Health and Disease·Krishnaswami Vijayaraghavan
Apr 5, 2013·PloS One·Gareth J McKayUNKNOWN Warren 3/UK GoKinD Study Group
May 8, 2014·Nature Reviews. Nephrology·Beatriz Fernandez-FernandezJesus Egido
Jan 31, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Pitchai BalakumarNanjaian Mahadevan
Nov 17, 2007·Progress in Neurobiology·Stefan KnechtJames A Levine
Feb 28, 2016·European Journal of Pharmacology·Elango BhakkiyalakshmiKunka Mohanram Ramkumar
Aug 28, 2014·Cholesterol·Ahmad GhorbaniMousa-Al-Reza Hadjzadeh
May 24, 2013·Clinical Biochemistry·Yong ZhouRisu Na
Feb 24, 2015·The Medical Clinics of North America·Nidhi BansalRuth S Weinstock
Oct 16, 2016·International Journal of Cardiology·Nasreen Al SayedPhilip Barter
Mar 31, 2015·International Journal of Immunopathology and Pharmacology·Samir Ahmed El-ShazlyMoamen S Refat
Jul 22, 2017·International Journal of Immunopathology and Pharmacology·Abdel Majid A AdamMoamen S Refat
Mar 11, 2008·Expert Review of Cardiovascular Therapy·Susanne H Meeuwisse-PasterkampBruce H R Wolffenbuttel
May 20, 2020·Metabolites·Mihnea-Alexandru GămanCamelia Cristina Diaconu
Jul 20, 2007·The Cochrane Database of Systematic Reviews·L NieldC D Summerbell

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.